This Weyerhaeuser Analyst Turns Bullish; Here Are Top 4 Upgrades For Monday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

  • Raymond James analyst Buck Horne upgraded the rating for Weyerhaeuser Company WY from Market Perform to Outperform and announced a $32 price target. Weyerhaeuser shares closed at $27.50 on Friday. See how other analysts view this stock.
  • HC Wainwright & Co. analyst Raghuram Selvaraju upgraded the rating for Aclaris Therapeutics, Inc. ACRS from Neutral to Buy and maintained the price target of $20. Aclaris Therapeutics shares closed at $2.72 on Friday. See how other analysts view this stock.
  • Piper Sandler analyst Crispin Love upgraded GCM Grosvenor Inc. GCMG from Neutral to Overweight and raised the price target from $12.5 to $14. GCM Grosvenor shares closed at $11.75 on Friday. See how other analysts view this stock.
  • Raymond James analyst Buck Horne upgraded the rating for PotlatchDeltic Corporation PCH from Market Perform to Outperform and announced a $45 price target. PotlatchDeltic shares closed at $38.75 on Friday. See how other analysts view this stock.

Considering buying WY stock? Here’s what analysts think:

Read This Next:

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!